Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 45.21B | 44.28B | 38.42B | 35.38B | 30.41B | 25.21B |
Gross Profit | 13.40B | 13.72B | 11.66B | 9.04B | 6.59B | 5.84B |
EBITDA | 12.57B | 15.04B | 13.85B | 11.15B | 5.87B | 5.20B |
Net Income | 9.38B | 8.82B | 8.75B | 6.81B | 4.75B | 4.31B |
Balance Sheet | ||||||
Total Assets | 93.15B | 92.34B | 88.47B | 78.52B | 62.77B | 59.20B |
Cash, Cash Equivalents and Short-Term Investments | 23.02B | 22.31B | 19.89B | 17.45B | 12.57B | 17.90B |
Total Debt | 17.08B | 17.35B | 15.44B | 13.12B | 4.44B | 2.51B |
Total Liabilities | 30.28B | 29.67B | 28.18B | 24.05B | 13.84B | 10.11B |
Stockholders Equity | 62.21B | 62.06B | 59.80B | 54.03B | 48.64B | 48.98B |
Cash Flow | ||||||
Free Cash Flow | 9.11B | 5.53B | 6.69B | 4.07B | -2.11B | -4.26B |
Operating Cash Flow | 11.76B | 11.43B | 13.36B | 11.48B | 7.22B | 4.95B |
Investing Cash Flow | -6.76B | -5.98B | -12.25B | -16.04B | -8.76B | -3.55B |
Financing Cash Flow | -5.39B | -5.00B | -769.84M | 7.06B | -2.90B | 8.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $54.52B | 13.85 | 14.68% | 2.41% | 0.27% | -2.64% | |
75 Outperform | $15.11B | 13.06 | 13.98% | 3.65% | 14.40% | 2.41% | |
72 Outperform | $16.50B | 19.64 | 39.01% | 1.23% | 23.70% | 31.33% | |
69 Neutral | $74.13B | 13.04 | 34.96% | 7.46% | 0.94% | 9.62% | |
69 Neutral | $14.99B | 28.78 | 32.43% | 1.94% | -2.55% | 59.07% | |
65 Neutral | $13.97B | 25.94 | 14.33% | 1.21% | -2.24% | -5.43% | |
64 Neutral | $10.95B | 16.37 | 8.81% | 1.96% | 2.68% | -15.33% |